Results 81 to 90 of about 1,195,086 (384)

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas in Morocco

open access: yesJEADV Clinical Practice
Background Few epidemiological studies on primary cutaneous lymphomas are available and related to limited populations. Objectives To characterize the epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas from a global ...
Fouzia Hali   +13 more
doaj   +1 more source

How can we get Iraq- and Afghanistan-deployed US Veterans to participate in health-related research? Findings from a national focus group study

open access: yesBMC Medical Research Methodology, 2018
Background Research participant recruitment is often fraught with obstacles. Poor response rates can reduce statistical power, threaten both internal and external validity, and increase study costs and duration.
Alyson J. Littman   +4 more
doaj   +1 more source

Does the recent evolution of Canadian mortality agree with the epidemiologic transition theory? [PDF]

open access: yes
After studying the epidemiologic transition’s situation in Canada, it is determined that the delimitation of temporal stages within the epidemiologic transition as put forward by Omran (1971, 1998), Olshansky and Ault (1986), Rogers and Hackenberg (1987)
Marie-Hélène Lussier   +2 more
core  

Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen   +11 more
wiley   +1 more source

Global aging: emerging challenges [PDF]

open access: yes, 2009
This repository item contains a single issue of The Pardee Papers, a series papers that began publishing in 2008 by the Boston University Frederick S. Pardee Center for the Study of the Longer-Range Future.
Crampton, Alexandra
core   +1 more source

Epidemiologic Signatures in Cancer.

open access: yesNew England Journal of Medicine, 2019
Interpreting Cancer Mortality The authors use 40 years of data on cancer incidence and mortality to produce curves that show changes in cancer incidence (decreasing, increasing, or staying stable) ...
H. Welch, Barnett S. Kramer, W. Black
semanticscholar   +1 more source

The McCance Brain Care Score and Mortality: Evidence From a Large‐Scale Population‐Based Cohort

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives This study aimed to examine the relationship between the McCance Brain Care Score (BCS) and mortality in the general population. Methods We conducted a prospective, population‐based cohort study using data from the UK Biobank. Participants with complete data enabling calculation of BCS and full mortality information were included ...
Zhiqiang Xu, Xiaoxiao Wang, Nan Li
wiley   +1 more source

The Cancer Transition in Japan since 1951 [PDF]

open access: yes
The overall trend of cancer mortality in Japan has been decreasing since the 1960s (age-standardized death rates for ages 30-69), though trends differ enormously among various forms of the disease.
John R. Wilmoth, Omer Gersten
core  

Home - About - Disclaimer - Privacy